WO2001009357A2 - Ethanol inducible expression system - Google Patents
Ethanol inducible expression system Download PDFInfo
- Publication number
- WO2001009357A2 WO2001009357A2 PCT/GB2000/002750 GB0002750W WO0109357A2 WO 2001009357 A2 WO2001009357 A2 WO 2001009357A2 GB 0002750 W GB0002750 W GB 0002750W WO 0109357 A2 WO0109357 A2 WO 0109357A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- promoter
- plant
- sequence
- alcr
- gene
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 81
- 230000001939 inductive effect Effects 0.000 title claims abstract description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title description 34
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 80
- 101150069317 alcA gene Proteins 0.000 claims abstract description 37
- 239000000411 inducer Substances 0.000 claims abstract description 37
- 241001136782 Alca Species 0.000 claims abstract description 29
- 102000034356 gene-regulatory proteins Human genes 0.000 claims abstract description 28
- 108091006104 gene-regulatory proteins Proteins 0.000 claims abstract description 28
- 101100434659 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) alcR gene Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 24
- 108700001094 Plant Genes Proteins 0.000 claims abstract description 23
- 241000351920 Aspergillus nidulans Species 0.000 claims abstract description 16
- 239000012634 fragment Substances 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 16
- 108091033319 polynucleotide Proteins 0.000 claims description 15
- 102000040430 polynucleotide Human genes 0.000 claims description 15
- 239000002157 polynucleotide Substances 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 150000002576 ketones Chemical class 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 230000005026 transcription initiation Effects 0.000 claims description 2
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 67
- 125000000217 alkyl group Chemical group 0.000 description 38
- 150000001875 compounds Chemical class 0.000 description 20
- 229940055577 oleyl alcohol Drugs 0.000 description 15
- 125000003118 aryl group Chemical group 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 14
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 13
- 125000005843 halogen group Chemical group 0.000 description 13
- 125000000623 heterocyclic group Chemical group 0.000 description 13
- 125000003342 alkenyl group Chemical group 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 125000000304 alkynyl group Chemical group 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 11
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000009261 transgenic effect Effects 0.000 description 11
- 125000003545 alkoxy group Chemical group 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- -1 mercapto, hydroxy Chemical group 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 244000061176 Nicotiana tabacum Species 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 125000004093 cyano group Chemical group *C#N 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 101100377798 Arabidopsis thaliana ABCD1 gene Proteins 0.000 description 5
- 101100054570 Caenorhabditis elegans acn-1 gene Proteins 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 125000004043 oxo group Chemical group O=* 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 101150053489 alcR gene Proteins 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 150000002431 hydrogen Chemical group 0.000 description 3
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N n-octadecyl alcohol Natural products CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 125000001117 oleyl group Polymers [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 101710103970 ADP,ATP carrier protein Proteins 0.000 description 2
- 101710133192 ADP,ATP carrier protein, mitochondrial Proteins 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 description 2
- 101710183938 Barstar Proteins 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 206010021929 Infertility male Diseases 0.000 description 2
- 208000007466 Male Infertility Diseases 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 101000832889 Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) Alcohol dehydrogenase 2 Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 244000038559 crop plants Species 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- AFENDNXGAFYKQO-VKHMYHEASA-N (S)-2-hydroxybutyric acid Chemical compound CC[C@H](O)C(O)=O AFENDNXGAFYKQO-VKHMYHEASA-N 0.000 description 1
- MZAGXDHQGXUDDX-JSRXJHBZSA-N (e,2z)-4-ethyl-2-hydroxyimino-5-nitrohex-3-enamide Chemical compound [O-][N+](=O)C(C)C(/CC)=C/C(=N/O)/C(N)=O MZAGXDHQGXUDDX-JSRXJHBZSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000251188 Holocephali Species 0.000 description 1
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 108010034634 Repressor Proteins Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 208000036815 beta tubulin Diseases 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- ZBPOCGOPSZYGNB-UHFFFAOYSA-N but-3-en-2-ol Chemical compound CC(C=C)O.CC(C=C)O ZBPOCGOPSZYGNB-UHFFFAOYSA-N 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- HITNTFQLHYWLDI-UHFFFAOYSA-N ethyl 2,4-dimethoxybenzoate Chemical compound CCOC(=O)C1=CC=C(OC)C=C1OC HITNTFQLHYWLDI-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 125000005553 heteroaryloxy group Chemical group 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- MKUWVMRNQOOSAT-UHFFFAOYSA-N methylvinylmethanol Natural products CC(O)C=C MKUWVMRNQOOSAT-UHFFFAOYSA-N 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000004069 plant analysis Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000012794 pre-harvesting Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- FDBYIYFVSAHJLY-UHFFFAOYSA-N resmetirom Chemical compound N1C(=O)C(C(C)C)=CC(OC=2C(=CC(=CC=2Cl)N2C(NC(=O)C(C#N)=N2)=O)Cl)=N1 FDBYIYFVSAHJLY-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001743 silencing effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000004953 trihalomethyl group Chemical group 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
Definitions
- the present invention relates to an expression system for use in plants and in particular to an expression system which utilises an exogenous chemical agent as a control mechanism.
- the present invention also relates to plants comprising such an expression system.
- the present invention further relates to a chemically-inducible promoter.
- promoter Gene expression is controlled by regions upstream (5 " ) of the protein encoding region. commonly referred to as the "promoter”.
- a promoter may be constitutive, tissue-specific, developmentally programmed or inducible.
- Manipulation of crop plants to improve characteristics requires the expression of foreign or endogenous genes in plant tissues.
- Such genetic manipulation therefore relies on the availability of means to control gene expression as required; for example, on the availability and use of suitable promoters which are effective in plants. It is advantageous to have a choice of a variety of different promoters so that the most suitable promoter may be selected for a particular gene, construct, cell, tissue, plant or environment. A range of promoters are known to be operative in plants.
- inducible promoter includes promoters which may be induced chemically.
- Particularly useful promoters are promoter sequences which are controlled by the application of an external chemical stimulus.
- the external chemical stimulus may be an agriculturally acceptable chemical, the use of which is compatible with agricultural practice and is not detrimental to plants or mammals. This allows particular gene expression to be controlled at particular stages of plant growth or development, by the presence or absence of a chemical which can be applied to the plants or seeds, for example by spraying or using known seed coating techniques.
- gene switch promoters. Examples of inducible switch systems include the ecdysone switch system as described in our
- ADH1 alcohol dehydrogenase I
- ale A the fungal organism Aspergillus nidulans which expresses the enzyme alcohol dehydrogenase I (ADH1 ) encoded by the gene ale A only when it is grown in the presence of various alcohols and ketones.
- the induction is relayed through a regulator protein encoded by the alcR gene which is constitutively expressed.
- inducer alcohol or ketone
- the regulator protein activates the expression of the inducer.
- high levels of the ADH 1 enzyme are produced under inducing conditions (i.e. when alcohol or ketone are present).
- the alcA gene and its product, ADH 1 are not expressed in the absence of inducer. Expression of alcA and production of the enzyme is also repressed in the presence of glucose.
- the alcA gene promoter is an inducible promoter, activated by the AlcR regulator protein in the presence of inducer (i.e. by the protein/ alcohol or protein/ ketone combination).
- inducer i.e. by the protein/ alcohol or protein/ ketone combination.
- the alcR and ale A genes have been cloned and sequenced (Lockington RA et al, 1985, Gene, 33: 137-149; Felenbok B et al , 1988, Gene, 73: 385-396; Gwynne et al, 1987, Gene, 51 : 205-216).
- Alcohol dehydrogenase (adh) genes have been investigated in certain plant species. In maize and other cereals they are switched on by anaerobic conditions. The promoter region of adh genes from maize contains a 300 base pair regulatory element necessary for expression under anaerobic conditions. No equivalent to the AlcR regulator protein has, however, been found in any plant. Hence the alcA/alcR type of gene regulator system is not known in plants. Constitutive expression of AlcR in plant cells does not result in the activation of endogenous adh activity.
- WO 93/21334 describes the production of transgenic plants which include such a system as a gene switch.
- This document specifically describes a chemically inducible plant gene expression cassette comprising a first promoter operatively linked to a regulator sequence which encodes a regulator protein, and an inducible promoter operatively linked to target gene, the inducible promoter being activated by the regulator protein in the presence of an effective exogenous inducer, whereby application of the inducer causes expression of the target gene.
- Exogenous chemical inducers which are applied in this case include those described by Creaser et al, J. Biochem.
- butan-2-one ethyl methyl ketone
- cyclohexanone acetone
- butan-2-ol 3-oxobutyric acid
- propan-2-ol ethanol
- alcohols are generally used as the exogenous chemical inducer.
- Other chemicals may, however, also be used a chemical inducers.
- R' is a lower alkyl, lower alkenyl or lower alkynyl group, and R : is a organic group such that R 2 COOH is an agriculturally acceptable acid.
- Hydrolysis of a compound of formula (I) yields an alcohol of formula (II)
- H0'R ' (II).
- agriculturally acceptable means that the compounds may be applied to a particular soil or crop situation without causing unacceptable levels of soil damage or phytotoxicity in the crop.
- lower alkyl as used herein includes C, profession 6 alkyl groups, preferably from C, .4 alkyl groups which may be straight or branched chain.
- lower alkenyl and lower alkynyl as used herein includes C 2 . 6 alkenyl and C 2 _ 6 alkynyl groups respectively, preferably from C 2 _ 4 alkenyl or C 2 . 4 alkynyl groups which may be straight or branched chain.
- Agriculturally acceptable esters such as those of formula (I) are suitably translocated into the target plant in which the gene control system is in place and/or hydrolysed either under environmental conditions or in the presence of a suitable catalytic moiety such as an enzyme or catalytic antibody, at rates which are appropriate to provide sufficient quantities of the activating alcohol at the required time in the necessary parts of the plant. These may vary depending upon the nature of the plant species being treated, the gene being expressed and the timing of the application of the ester.
- Esters such as the compounds of formula (I) are advantageous in that they are easier to handle than the corresponding alcohols. These compounds have been found to produce the desired effect in terms of gene activation.
- the compound should be applied at a sufficient period of time prior to the required gene activation to allow hydrolysis to occur and this should be reasonable depending upon factors such as the growth stage of the plant at which activation is required. If the rate of hydrolysis is relatively slow, the time of application may be earlier in order to ensure that sufficient hydrolysis has occurred by the time the plant is at the growth stage at which gene activation is required. Where this is difficult, more rapidly hydrolysing esters may be selected.
- more than one ester, with differing rates of hydrolysis may be applied in a single treatment.
- an effective "slow release" of activating alcohol can be achieved so that gene expression may be prolonged over the desired period. This means that repeated applications of chemical may be avoided and "one-shot" treatments are possible.
- alcohols of formula (II) include methanol, ethanol. propan- 1-ol, propan-2-ol, butan-2-ol or but-3-en-2-ol.
- the alcohol of formula (II) is a lower alkyl alcohol wherein the alkyl group has from 1 to 4 carbon atoms and may be either branched, or linear.
- Preferred groups for R' include ethyl, n-propyl and n-butyl.
- a particularly preferred example of a compound of formula (II) is ethanol.
- R 2 group The precise nature of the R 2 group is immaterial provided that it gives rise to an agriculturally acceptable acid at an appropriate rate in the particular target plant to which it is applied. Rates of hydrolysis can be determined using routine methods for example as described by G. Mitchell et al, Pestic. Sci (1995) 44:49-58. and preferably by testing against whole plant systems. What is appropriate in any particular instance will depend upon a variety of factors including the nature of the gene expression of which is being controlled, the particular plant in which the gene is expressed and other external conditions. The rate of hydrolysis should be sufficient to allow the desired effect, for example, reversible male sterility, to be seen at an appropriate period of time after application of the chemical inducer.
- R 2 however may be selected such that the resultant acid of formula (III)
- R includes optionally substituted alkyl. optionally substituted cycloalkyl. optionally substituted alkenyl, optionally substituted alkynyl. optionally substituted aryl or optionally substituted heterocyclyl.
- alkyl includes straight or branched alkyl chains, suitably containing up to 10 carbon atoms, preferably from 1 to 6 carbon atoms.
- alkenyl and “alkynyl” includes unsaturated straight or branched chains containing up to 10 carbon atoms, preferably from 2 to 6 carbon atoms.
- aryl includes phenyl and naphthyl.
- heterocyclic includes rings containing up to 10, preferably up to 7 atoms, up to three of which are selected from oxygen, sulphur or nitrogen. These rings may be single rings or may be in the form of fused ring systems and these may be aromatic or non-aromatic in nature.
- halo or “halogen” includes chlorine, fluorine, bromine and iodine.
- alkoxy relates to an alkyl group as defined above, linked with an oxygen atom.
- R 2 is an optionally substituted C M0 alkyl group which may be linear or branched.
- Preferred alkyl groups R 2 are linear and contain 3 to 8 carbon atoms, in particular 5 carbon atoms.
- Suitable optional substituents for hydrocarbyl groups R", R 12 or R 13 include halo, perhaloalkyl such as trifluoromethyl, mercapto, hydroxy, alkoxy, oxo, heteroaryloxy. alkenyloxy. alkynyloxy, alkoxyalkoxy, aryloxy (where the aryl group may be substituted by halo, nitro. or hydroxy), cyano, nitro, amino, mono- or di-alkyl amino. alkylamido or S(O) p R 14 where m and R i4 are as defined above.
- R 2 are one or more groups selected from oxo; alkoxycarbonyl in particular lower alkoxy carbonyl; cyano; halo such as chloro, fluoro or bromo; phenyl optionally subsituted with amino or mono-or dialkyl amino or alkyl such as methyl; OR 3 where R 3 is alkyl or heterocyclyl optionally substituted by halo or alkyl; S(O) m R" where m is 0 or 2 and R" is alkyl or phenyl optionally substituted by alkyl; NR 5 R 6 or C(O)NR 5 R ⁇ where R 5 is hydrogen, methyl or methoxyethyl and R 6 is alkyl such as methyl, phenyl or benzyl optionally substituted with halo such as fluoro or chloro.
- alkyl such as methyl or trifluromethyl or alkoxycarbonyl where the alkyl moiety may carry a further alkoxycarbonyl group , or R 6 is heterocyclyl such as thiazinyl optionally substituted by alkyl and/or acetyl; -NR 4 C(O) p R 3 where p is 2, R 3 is alkyl and R 4 is alkyl optionally substituted with alkoxy carbonyl such as ethoxyl carbonyl alkyl; -NR 3 S(O) m R 4 where R 3 is hydrogen, R 4 is phenyl optionally substituted by halo such as chloro, and m is 2; C(O)NR 3 NR 5 R 6 where R 3 and R 5 are hydrogen and R 6 is phenyl optionally substituted by halo or alkoxy such as methoxy; S(O) m NR 5 R 6 where m is 2, R 5 is hydrogen and R 6 is alkyl optionally substituted by one or more al
- substituents for alkyl, alkenyl or alkynyl groups R 2 include alkoxycarbonyl in particular where the alkoxy group is a lower alkyl group; alkoxy and in particular two alkoxy groups in the form of a dialkyl acetal; cyano or optionally substituted heterocyclyl.
- Preferred substituents include, but are not limited to lower alkoxycarbonyl groups and dialkyl acetals. Alkoxycarbonyl groups and dialkyl acetals are of particular interest when the alkyl group of the substituent is the same as R' in the compound of formula (I) since on hydrolysis these give rise to more inducer chemical of formula (II) .
- a particular aryl group for R 2 is phenyl.
- Suitable optional substituents for cycloalkyl, aryl and heterocyclyl groups R ⁇ and for aryl or heterocyclyl substituents on the above-mentioned alkyl, alkenyl or alkynyl groups R 2 include halo; haloalkyl; cyano; nitro; amino or mono- or di-alkyl amino; hydroxy; alkoxy, thioalkyl, alkyl or alkoxycarbonyl wherein the alkyl moiety of any of these may be optionally substituted with for example one or more groups selected from halo, alkoxy. cyano. alkoxycarbonyl, amino, mono- or di-alkyl amino, aryl or carboxylate or salts or esters thereof; cycloalkyl; or heterocyclyl.
- Particularly suitable substituents for aryl or heterocyclyl groups R 2 include alkoxy in particular lower alkoxy such as methoxy, alkyl in particular lower alkyl, alkoxycarbonyl in particular lower alkoxycarbonyl and halogen.
- a particular sub-group of compounds of formula (I) are compounds of formula ( 1 A)
- R 1 is as defined above in relation to formula (I)
- n is an integer of from 2 to 4 and R'° is an alkyl, alkenyl or alkynyl group any of which may be optionally interposed with a heteroatom.
- a cycloalkyl, heterocyclic group or aryl group, or R'° is a cycloalkyl or aryl group of valency n.
- R'° is an alkyl or aryl group of valency n.
- Particularly preferred compounds of formula (I) include:- Ethyl 2-n-pentyl-3-oxobutanoate (Compound No. 49); Triethyl 2-carboxyheptan-l,7-dioate (Compound No. 53); and Ethyl 2,4-dimethoxybenzoate ( Compound No. 60).
- Compounds of formula (I) are either known compounds of they can be prepared from known compounds using conventional methods.
- Compounds of formula (I) may be hydrolysed in the target plant either chemically, or enzymatically by a naturally occurring enzyme in the target plant or by an enzyme introduced by genetic engineering into the plant and expressed within the plant, or by an appropriate catalytic antibody, or catalytically active portion of a catalytic antibody introduced by genetic engineering into the plant and expressed within the plant.
- Suitable enzymes include, but are not limited to, esterases and lipases.
- Suitable catalytic antibodies may be generated by standard techniques from analogues of a tetrahedral ester hydrolysis transition state, e.g. as for the hydrolysis of the pro-drug ester of chloramphenicol, when appropriate phosphonates were used, Ole K et al., 1998, J. Mol. Biol., 281 :501 -51 1. and for the detoxification of cocaine by methyl ester hydrolysis. Mets B et al., 1998. Proc. Nat. Acad. Sci. USA. 95: 10176-10181.
- a product of this metabolism is ethanol which can act as a chemical inducer as described above.
- a diluent for controlling expression of a target gene in an organism having a chemically-inducible gene expression cassette comprising an inducible promoter operatively linked to the target gene wherein the inducible promoter is induced by the application to the organism of (a) above.
- the organism is a plant such as a crop plant and the diluent (c) may be, for example, water.
- component (a) in the above formulations depends upon the character of the inducible promoter present in the expression system.
- component (a) are a C,-C 6 alcohol or a C 3 -C 9 ketone, and preferably, ethanol or propan-2-ol. These components act as inducers for example, of the ale switch system as described above.
- Component (b) of the formulation is preferably a polyethoxylated oleyl, lauryl, stearyl or cetyl alcohol. It is more preferably a polyoxyethylene-oleyl alcohol having a mean molar ethylene oxide content in the range of 0 to 35 and more preferably in the range of 2 to 20.
- Component (b) is, however, preferably a polyoxyethylene-(20)-oleyl alcohol (the number in brackets indicates the mean ethylene oxide content per molecule).
- Such products are commercially available as BR1J 92TM.
- Component (b) of the formulation is preferably at a concentration of about 0.5% wt/wt or less. It is preferably at a concentration between about 0.2% wt/wt and 0.5% wt wt.
- the formulation described includes as component (b). a hydrogen or methyl end-capped trisiloxane polyethoxylate
- component (b) is a methyl end-capped trisiloxane polyethoxylate.
- the methyl end-capped trisiloxane polyethoxylate preferably has a mean molar ethylene oxide content of between 4 and 12 per molecule and is most preferably 8 per molecule.
- Such products are commercially available as SILWET 77TM (SILWET is a trademark of Witco).
- the methyl end-capped trisiloxane polyethoxylate is preferably at a concentration of about 0.5% wt/wt or less and more preferably at a concentration between about 0.2% and 0.5% wt wt.
- Component (a) of the formulation described is preferably at a concentration of about 5% wt/wt or less and more preferably at a concentration between about 2% and 5% wt/wt.
- Component (c) of the formulation is preferably at a concentration between about 90% and 98% wt/wt.
- an agricultural formulation comprising
- component (b) of the formulation is suitably a polyethoxylated oleyl. lauryl. stearyl or cetyl alcohol, and preferably a polyoxyethylene-oleyl alcohol.
- the polyoxyethylene-oleyl alcohol has a mean molar ethylene oxide content in the range of 2 to 20, such as a polyoxyethylene-(2)-oleyl alcohol, a polyoxyethylene-(10)-oleyl alcohol or a polyoxyethylene-(20)-oleyl alcohol.
- component (a) which is preferably ethanol or propan-2-ol, is suitably at a concentration between about 2% to less than 5% wt/wt.
- the concentration of component (B) is preferably about 0.5% wt/wt or less.
- a further agricultural formulation comprising
- Component (a) is preferably at a concentration between about 2% and 5% wt wt.
- component (b) may be a polyethoxylated oleyl, lauryl, stearyl or cetyl alcohol, and is preferably a polyoxyethylene- oleyl alcohol, with a mean molar ethylene oxide content in the range of 2 to 20.
- Particular examples of component (b) are polyoxyethylene-(2)-oleyl alcohol, polyoxyethylene-(l ⁇ )- oleyl alcohol and polyoxyethylene-(20)-oleyl alcohol.
- the formulations increase the effectiveness of ethanol as an inducer of the alcA/alcR promoter.
- the use of polyoxyethylene-oleyl alcohol surfactants and/or methyl end-capped trisiloxane polyethoxylate adjuvants in combination with the known chemical inducers for the alcA/alcR promoter has been found to increase uptake of the formulation by a plant significantly, thereby allowing greater control of a target gene which may be operatively linked to the inducible promoter. It is desirable to use a plant gene expression system which provides higher levels of inducible expression in transgenic plants and which, preferably, also provides a higher proportion of high expressing plant lines.
- the present invention therefore seeks to provide an improved plant gene expression system.
- the present invention seeks to provide a chemically-inducible promoter based on the ale A/ alcR promoter system.
- a chemically- inducible plant gene expression cassette comprising a first promoter operatively linked to the alcR regulator protein sequence obtainable from Aspergillus nidulans which encodes the AlcR regulator protein, and an inducible promoter obtainable from the alcA gene promoter of Aspergillus nidulans operatively linked to a target gene, the inducible promoter being activated by the regulator protein in the presence of an effective exogenous inducer whereby application of the inducer causes expression of the target gene and wherein the alcA promoter has three or more binding sites for the AlcR protein.
- the exogenous inducer of plant gene expression is preferably an alcohol, ketone, a hydrolysable ester or a formulation comprising a volatile chemical inducer, a polyoxyethylated C 10 -C 20 alcohol or a trisiloxane polyoxylate and a diluent.
- the inducible promoter of the plant gene expression cassette is a chimaeric promoter and preferably comprises the polynucleotide sequence of SEQ. ID. NO. 3 or at least part of a sequence that has substantial identity therewith or a variant or fragment thereof.
- the inducible promoter sequence of the plant gene expression cassette is a non-chimaeric promoter.
- the inducible promoter of the plant gene expression cassette preferably comprises the polynucleotide sequence of SEQ. ID. NO. 2 or the polynucleotide sequence of SEQ. ID. NO. 4 or at least part of a sequence that has substantial identity therewith or a variant or fragment thereof.
- an expression system comprising a gene expression cassette as defined above.
- a plant cell comprising a gene expression cassette as defined above.
- the gene expression cassette is incorporated, preferably stably incorporated, into the plant's genome.
- plant tissue comprising a plant cell according to the present invention.
- a plant comprising a plant cell according to the present invention.
- a plant obtainable from a plant as defined above.
- a seed obtainable from a plant as defined above.
- a method for controlling plant gene expression comprising transforming a plant cell with a chemically inducible plant gene expression cassette comprising a first promoter operatively linked to the alcR regulator protein sequence obtainable from Aspergillus nidulans which encodes the AlcR regulator protein, and an inducible promoter obtainable from the alcA gene promoter of Aspergillus nidulans operatively linked to a target gene, the inducible promoter being activated by the regulator protein in the presence of an effective exogenous inducer whereby application of the inducer causes expression of the target gene and wherein the ale A promoter has three or more binding sites for the AlcR protein.
- a chemically inducible promoter comprising an upstream region comprising a promoter regulatory sequence obtainable from the ale A gene promoter of Aspergillus nidulans and a downstream region comprising a transcription initiation sequence, wherein the ale A gene promoter sequence comprises three or more binding sites for the AlcR regulatory protein.
- the promoter is a chimaeric promoter. It preferably comprises the polynucleotide sequence of SEQ. ID.NO 3 or at least part of a sequence that has substantial identity therewith or a variant or fragment thereof.
- the promoter may be a non-chimaeric promoter. It preferably comprises the polynucleotide sequence of SEQ. ID.NO 2 or at least part of a sequence that has substantial identity therewith or a variant or fragment thereof.
- the promoter comprises 4 direct repeat binding sites for the AlcR protein. It preferably comprises the polynucleotide sequence of SEQ. ID.NO 4 or at least part of a sequence that has substantial identity therewith or a variant or fragment thereof.
- a chemically- inducible plant gene expression cassette comprising a first promoter operatively linked to the alcR regulator protein sequence obtainable from Aspergillus nidulans which encodes the AlcR regulator protein, and an inducible promoter obtainable from the alcA gene promoter of Aspergillus nidulans operatively linked to a target gene, the inducible promoter being activated by the regulator protein in the presence of an effective exogenous inducer whereby application of the inducer causes expression of the target gene, wherein the ale A promoter has three or more binding sites for the AlcR protein and wherein the inducible promoter is a non-chimaeric promoter comprising 4 direct repeat binding sites for the AlcR protein.
- a chemically-inducible promoter comprising an upstream region comprising a promoter regulatory sequence obtainable from the ale A gene promoter of Aspergillus nidulans comprising three or more binding sites for the AlcR protein, wherein the promoter is a non- chimaeric promoter comprising 4 direct repeat binding sites for the AlcR protein.
- target gene with reference to the present invention means any gene of interest (GOI).
- a gene may be an endogenous plant gene or a foreign gene, and may be a single gene or a series of genes.
- the target gene sequence may encode at least part of a functional protein or an antisense sequence.
- Typical examples of a GOI include a gene which gives rise to the desired characteristic or phenotype itself.
- the inducible promoter may control expression of a repressor protein which inhibits expression of a target gene, for example by interacting with an operator sequence upstream of the target gene so as to prevent expression of the gene (for example as known in the bacterial tet and lac operator/repressor systems).
- the GOI under the control of the inducible promoter may express a protein which interacts with another protein to inhibit the activity thereof, as for example in the barnase/ barstar system which barnase will inhibit or kill cells in the absence of barstar.
- Other disrupter genes include ribonuclease, ⁇ -tubulin or adenine nucleotide translocator (ANT).
- substantially identical covers identity with respect to at least the essential nucleic acids/ nucleic acid residues of the promoter sequence providing the homologous sequence acts as a chemically inducible promoter which is capable of inducing a GOI.
- a preferred level of identity is shown when 60% or more of the nucleotides are common with the promoter sequence of the present invention, more preferably 65%, 70% or 75%, even more preferably 80% or 85% and, especially preferred are 90%, 95%m 98% or 99% or more levels of identity.
- BESTFIT for example, compares two sequences and produces an optimal alignment of the most similar segments. GAP enables - 11 .
- sequences to be aligned along their whole length finds the optimal alignment by inserting spaces in either sequence as appropriate.
- the comparison is made by alignment of the sequences along their whole length.
- the term "variant thereof with reference to the present invention means any substitution of variation of . modification of , replacement of, deletion of or the addition of one or more nucleic acid(s) from or to the promoter sequence providing the resultant sequence exhibits inducible promoter of a particular GOI.
- the term also includes DNA which substantially hybridises to the DNA of the present invention and which functions as a chemically inducible promoter. Preferably, such hybridisation occurs at. or between, low and high stringency conditions.
- low stringency conditions can be defined as 3 x SSC at about ambient temperature to about 65 °C, and high stringency conditions as 0.1 x SSC at about 65 °C.
- SSC is the name of the buffer of 0.15M NaCl, 0.015M trisodium citrate. 3 x SSC is three times as strong as SSC and so on.
- sequences according to the present invention may also be used in the production of other variants using molecular evolution and/ or DNA shuffling techniques.
- molecular evolution and/ or DNA shuffling techniques are described, for example, in US Patent No. 5 605 793, US Patent No. 5 81 1 238 and US Patent No. 5 830 721.
- this technique involves expression of a gene (or nucleic acid sequence) in a microbial expression system such as Escherichia coli.
- the particular system selected must be validated and calibrated to ensure that biologically active peptides are expressed, which may be readily achieved using an in vivo bioassay.
- the gene, or preferably a collection of related genes from different species may be subject to mutagenic polymerase chain reaction (PCR) as is known in the art.
- Fragmentation of the products and subsequent repair using PCR leads to a series of chimaeric sequences reconstructed from parental variants. These chimaeras are then expressed in the microbial system which can be screened in the usual way to determine active mutants, which may then be isolated and sequenced. Reiteration of this molecular evolution DNA shuffling cycle may lead to progressive enhancement of the desired properties.
- the advantage of a technique of this nature is that it allows a wide range of different mutations, including multi-mutational block exchanges, to be produced and screened.
- Particular variants are those derivable from polynucleotides of SEQ. ID. Nos 2. 3 and/ or 4. Preferably such variants will have improved chemical inducibility compared to known promoter sequences.
- fragment thereof includes one or more regions of the basic sequence which retain promoter activity. When the fragments comprise one or more regions, they may be joined together or they may be spaced apart by additional bases.
- DNA construct which is synonymous with terms such as “cassette”, “hybrid “ , “conjugate “ and “vector” - includes a target gene directly or indirectly attached to the regulator promoter, such as to form a cassette.
- An example of an indirect attachment is the provision of a suitable spacer group such as an intron sequence intermediate the promoter and the target gene.
- the DNA sequences may, furthermore, be on different vectors and are therefore not necessarily located on the same vector.
- fused in relation to the present invention which includes direct or indirect attachment.
- constructs also include plasmids and phage which are suitable for transforming a cell of interest.
- expression system means that the system defined above can be expressed in an appropriate organism, tissue, cell or medium.
- the system may comprise one or more constructs and may also comprise additional components that ensure the increased expression of the target gene.
- Any transformation method suitable for the target plant or plant cells may be employed, including infection by Agrobacterium tumefaciens containing recombinant Ti plasmids, electroporation, microinjection of cells and protoplasts, microprojectile bombardment, bacterial bombardment, particularly the "fibre” or “whisker” method, and pollen tube trnasformation.
- the transformed cells may then in suitable cases be regenerated into whole plants in which the new nuclear material is stably incorporated into the genome. Both transformed monocot and dicot plants may be obtained in this way.
- Examples of genetically modified plants which may be produced include dicotyledenous and moncotyledonous plant such as field crops, cereals, fruits and vegetables such as : canola, sunflower, tobacco, sugarbeet, cotton, soya, maize, wheat, barley, rice, sorghum, tomatoes, mangoes, peaches, apples, pears, strwberries, bananas, melons, potatoes, carrot, lettuce, cabbage and onion.
- dicotyledenous and moncotyledonous plant such as field crops, cereals, fruits and vegetables such as : canola, sunflower, tobacco, sugarbeet, cotton, soya, maize, wheat, barley, rice, sorghum, tomatoes, mangoes, peaches, apples, pears, strwberries, bananas, melons, potatoes, carrot, lettuce, cabbage and onion.
- An advantage of the chemically-inducible promoter of the present invention is that it has increased and greater uniformity in inducible expression levels over known inducible promoters.
- the chemically-inducible promoter of the present invention therefore, has enhanced effects over known inducible promoters in areas such as in agriculture.
- a further advantage of the plant gene expression system is that it provides higher levels of inducible expression in transgenic plants and that it also provides a higher proportion of high expressing lines in the primary transformant plant population.
- the ale A promoter may be enhanced by the addition of extra alcR binding sites and/ or the removal of the 35S minimal promoter.
- the alcA promoter described in International Publication No. WO 93/21334 comprises a -33 base pair 35S minimal promoter sequence at the 3' end, which replaces the native alcA promoter sequence in this region.
- the promoter was made chimaeric since it was believed that expression of the fungal promoter would be enhanced in a plant system.
- This version. pSRNlACNl has been demonstrated to be a good inducible promoter system in several plant species.
- ale A constructs Three altered ale A constructs have been made. The first, pSRN l ACN2, was made with the native ale A sequence replacing the 35S sequence in this region and has three binding sites for the AlcR regulatory protein.
- the second, pSRNlACN3, was made with almost the full native ale A promoter sequence and has three binding sites for the AlcR regulatory protein.
- This construct also comprises a - 33 base pair 35S minimal promoter.
- the third version of the ale A construct, pSRNlACN8, comprises 100 bases of the native alcA sequence at the 3' end of the promoter and four inverted repeats of the alcR binding sites placed upstream of this.
- pSRNlACNl represents the original alcA promoter which has only two alcR binding sites.
- Figure 1 shows the vector constructs for pACNl , pACN2, pACN3 and pACN8:
- Figure 2 shows the nucleic acid sequences, SEQ. ID. Nos 1-4, for the inducible promoter in each of the vector constructs;
- Figure 3 shows the results showing expression levels of primary transgenic tobacco plants with different ALC optimisation constructs, SRN 1 ACN 1 , SRN 1 ACN2, SRN 1 ACN8 and SRN1ACN1 ;
- Figure 4 shows a comparison of CAT protein levels in ALCCAT primary tranformant populations 72 hours after induction including those showing zero activity
- Figure 5 shows a comparison of CAT protein levels in ALCCAT primary transformant populations 72 hours after induction excluding those showing zero activity
- Figure 6 shows the pCa MVCN vector
- Figure 7 shows the pAN204 vector.
- ALC switch constructs Four versions of the ALC switch constructs were transformed into tobacco. These constructs comprised a cassette with an alcR gene under the control of a 35S promoter and nos terminator (described hereafter as SRN), and a CAT reporter gene under the control of an alcA inducible promoter and with a nos terminator (described hereafter as ACN). However, the alcA promoter in the ACN cassette had been altered in three of the constructs as described below (see Figures 1 and 2). 1.
- the plasmid SRN 1 ACN 1 is the same as described in WO 93/21334. It has the minimal 35S sequence in the ale A promoter as described and comprises two alcR binding sites.
- the plasmid SRN1ACN2 differs from SRN 1 ACN 1 in that the native ale A promoter is used which contains no minimal 35S sequence. It also contains more of the ale A sequence at the 5 ' end. This plasmid comprises three alcR binding sites.
- the plasmid SRN1ACN3 differs from SRN1ACN2 in that it contains the minimal 35S sequence in the ale A promoter in place of the al A sequence at the 5' end.
- the plasmid SRN1ACN8 contains 98 bases of the 3' end of the alcA promoter of SRN 1 ACN 1, and in addition there are 4 direct repeat alcR binding sites of sequence GTCCGCACGGGATGTCCGCACGG located at the 5' end of this alcA promoter region.
- pACNl in SRN1ACN1 1.
- a pCaMVCN vector ( Figure 6) with the 35S promoter, E coli CAT reporter gene and nos terminator was obtained. The Hindlll site 3' to the nos terminator was removed by blunt ending and religation. The plasmid was then cut with Bglll and Clal and the resulting recessed nucleotides filled in with Klenow DNA polymerase. The fragments were blunt end ligated to form pCaMVCN ⁇ H.
- the ale A promoter was fused to the CaMV35S promoter minimal sequence using recombinant PCR technology, utilising an identical core sequence of TCTATATAA in the TATA boxes of the two promoters. In this way, the sequence 3' to this in the ale A promoter was replaced with 32 bases of CaMV35S sequence. • A fragment of approximately 246bp was amplified from a pAN204 plasmid
- the two PCR products were purified and amplified by recombinant PCR with Al and Cl oligonucleotides to produce a fragment of approximately 600bp.
- the native alcA promoter was amplified by PCR from the clone pAN204, adding Hindlll, EcoRI and Pad to the 5' end and BamHI, Notl to the 3' end.
- the plasmid pACNl was digested with Hindlll (partial digest) and BamHI, which removed the alcAI 35S minimal sequence promoter. The fragment left was the vector with the CAT gene and nos terminator.
- the PCR product of the native ale A promoter was digested with Hindlll and BamHI, and ligated into the vector with the CAT gene and nos terminator from (2) above.
- pACN3 in pSRNACN3 1.
- the native alcA promoter was amplified by PCR from the genomic clone pAN204
- ⁇ /c ⁇ /minimal 35S chimeric promoter was amplified by PCR from pACNl . adding EcoRI, Hindlll to the 5' end and Pstl, Sail BamHI and Notl to the 3' end.
- Oligonucleotides based on the -140 bp direct repeat alcR binding site in the native ale A promoter were synthesised and annealed to form a linker.
- this ligation mix contained a mixture of Xhol/Sall; Xhol/Xhol; and Sail/Sail ligated ends.
- the fragments with the Sall/Xhol ligated ends are required to form multimers of the direct repeat.
- the ligation products are digested with Xhol and Sail to digest all the Xhol/Xhol and Sail/Sail joins, but do not cut the required Sall/Xhol ends. The digests are run on a 2.5%) agarose gel and bands of visible sizes are extracted.
- NBM media MS supplemented with lmg/litre 6-benzylamino purine (6-BAP), O. lmg/litre napthalene acetic acid (NAA).
- NBM media MS supplemented with lmg/litre 6-benzylamino purine (6-BAP), O. lmg/litre napthalene acetic acid (NAA).
- NBM medium supplemented with carbenicillin (500mg/L) and kanamycin (lOOmg/L).
- 1 shoot per leaf disc was transferred to NBM medium supplemented with carbenicillin (200mg/L) and kanamycin (lOOmg/L).
- shoots that had rooted were transferred to fresh medium
- leaf samples were taken from all the kanamycin resistant plants in tissue culture and extracts made for PCR analysis.
- the oligonucleotides 35Sjpl and AlcRjp4R were used to amplify extracts from all four populations.
- the PCR conditions were 94°C, 30 seconds; 60°C, 30 seconds and 72°C, 60 seconds, for 30 cycles.
- oligonucleotides alcRjp2 and catjp2R were used to screen the SRN 1 ACN 1 population.
- the PCR conditions were 94°C, 45 seconds; 60°C, 45 seconds and 72°C, 90 seconds, for 30cycles.
- the percentage of plants expressing CAT protein after ethanol induction is higher in the SRN1ACN2 and SRN1ACN8 populations than in the SRN 1 ACNl population.
- the number of transgenic plants with high expression levels after induction with ethanol (10-30ngCAT/mg total protein) is higher in the SRN1ACN2 population than in the SRN 1 ACNl population.
- constructs ACN2, 3 and 8 show more consistent expression levels than the original ACNl construct i.e. the spread of values is more even and the mean corresponds more closely to the median in ACN2, 3 and 8.
- alcA promoter functions well as an inducible promoter in plants both with and without the minimal 35S sequence. Both the native (no minimal 35S promoter) and deleted alcA promoter fragment of 98 bases with alcR binding sites added at - 37 -
- the minimal 35S promoter is not required in the alcA promoter for expression of the alcA/ alcR inducible system in plants.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU60012/00A AU6001200A (en) | 1999-08-02 | 2000-07-18 | Expression system |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9918154.7A GB9918154D0 (en) | 1999-08-02 | 1999-08-02 | Expression system |
| GB9918154.7 | 1999-08-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001009357A2 true WO2001009357A2 (en) | 2001-02-08 |
| WO2001009357A3 WO2001009357A3 (en) | 2001-10-11 |
Family
ID=10858410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2000/002750 WO2001009357A2 (en) | 1999-08-02 | 2000-07-18 | Ethanol inducible expression system |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6001200A (en) |
| GB (1) | GB9918154D0 (en) |
| WO (1) | WO2001009357A2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005021766A1 (en) * | 2003-09-02 | 2005-03-10 | Martin Fussenegger | Regulatable gene expression in mammalian cells and mammals |
| WO2006005520A3 (en) * | 2004-07-08 | 2006-03-23 | Dlf Trifolium As | Means and methods for controlling flowering in plants |
| EP2100961A1 (en) | 2008-03-04 | 2009-09-16 | Icon Genetics GmbH | Method of protease production in plants |
| WO2012099664A1 (en) * | 2011-01-18 | 2012-07-26 | Syngenta Participations Ag | Methods and compositions for modified ethanol inducible promoter systems |
| US11340216B2 (en) | 2016-09-13 | 2022-05-24 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the positive selection of protein destabilizers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT637339E (en) * | 1992-04-13 | 2002-03-28 | Syngenta Ltd | DNA BUILDINGS AND PLANS THAT INCORPORATE THEM |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| GB9516241D0 (en) * | 1995-08-08 | 1995-10-11 | Zeneca Ltd | Dna constructs |
| GB9902234D0 (en) * | 1999-02-01 | 1999-03-24 | Zeneca Ltd | Expression system |
-
1999
- 1999-08-02 GB GBGB9918154.7A patent/GB9918154D0/en not_active Ceased
-
2000
- 2000-07-18 WO PCT/GB2000/002750 patent/WO2001009357A2/en active Application Filing
- 2000-07-18 AU AU60012/00A patent/AU6001200A/en not_active Abandoned
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005021766A1 (en) * | 2003-09-02 | 2005-03-10 | Martin Fussenegger | Regulatable gene expression in mammalian cells and mammals |
| WO2006005520A3 (en) * | 2004-07-08 | 2006-03-23 | Dlf Trifolium As | Means and methods for controlling flowering in plants |
| US8237013B2 (en) | 2004-07-08 | 2012-08-07 | Dlf-Trifolium A/S | Means and methods for controlling flowering in plants |
| EP2100961A1 (en) | 2008-03-04 | 2009-09-16 | Icon Genetics GmbH | Method of protease production in plants |
| WO2012099664A1 (en) * | 2011-01-18 | 2012-07-26 | Syngenta Participations Ag | Methods and compositions for modified ethanol inducible promoter systems |
| CN103314115A (en) * | 2011-01-18 | 2013-09-18 | 先正达参股股份有限公司 | Methods and compositions for modified ethanol inducible promoter systems |
| US20130291233A1 (en) * | 2011-01-18 | 2013-10-31 | Queensland University Of Technology | Methods and Compositions for Modified Ethanol Inducible Promoter Systems |
| US9434953B2 (en) | 2011-01-18 | 2016-09-06 | Syngenta Participations Ag | Methods and compositions for modified ethanol inducible promoter systems |
| US11340216B2 (en) | 2016-09-13 | 2022-05-24 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the positive selection of protein destabilizers |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001009357A3 (en) | 2001-10-11 |
| GB9918154D0 (en) | 1999-10-06 |
| AU6001200A (en) | 2001-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016399292B2 (en) | Herbicide tolerant protein, encoding gene and use thereof | |
| CA2219979C (en) | Dna sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides | |
| US7115798B1 (en) | Methods for regulated expression of triats in plants using multiple site-specific recombination systems | |
| JP2015534834A (en) | Transfer DNA transfer mediated by TAL | |
| EP2183355B1 (en) | Compositions and methods for the modification of physiological responses in plants | |
| KR20010041129A (en) | Pollen specific promoter | |
| WO2014144094A1 (en) | Tal-mediated transfer dna insertion | |
| JPH11510694A (en) | DNA construct | |
| CN111433363A (en) | Plants having increased abiotic stress tolerance and polynucleotides and methods for increasing abiotic stress tolerance in plants | |
| CN110628733B (en) | Herbicide tolerance proteins, their encoding genes and uses | |
| WO2007033587A1 (en) | A method for isolating a bi-directional gene promotor and the use thereof | |
| WO1997013851A1 (en) | Improvement of fruit quality by inhibiting production of lipoxygenase in fruits | |
| WO2001009357A2 (en) | Ethanol inducible expression system | |
| CN112342236A (en) | Application of rice histone methyltransferase in enhancing crop drought resistance and improving yield per plant | |
| JP6202832B2 (en) | Environmental stress-tolerant plant having high seed yield and its production method | |
| US11319552B2 (en) | Methods for improving transformation frequency | |
| EP4450617A1 (en) | Mutated hydroxyphenylpyruvate dioxygenase polypeptide, and coding gene and use thereof | |
| CN102731633B (en) | Plant side branch number related transcription factor AtDOF4.2 and its coding gene and application | |
| US6989472B1 (en) | cDNA sequence transcribing an mRNA encoding the terminal oxidase associated with carotenoid biosynthesis, and uses thereof | |
| JP4059897B2 (en) | Rice nicotianamine synthase gene promoter and use thereof | |
| JP2004329210A (en) | Genes that confer salt stress tolerance | |
| WO2000044917A1 (en) | Inducible expression system for use in plants | |
| US12297438B2 (en) | Gene expression elements and systems and use thereof | |
| JP4085110B2 (en) | Germin-like protein 4 gene promoter and use thereof | |
| WO2003052109A1 (en) | Method of increasing the transgene-coded biomolecule content in organisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |